Philips Q2 2025 Financial Results and Outlook

Koninklijke Philips N.V. reported its Q2 2025 financial results, showing a 6% increase in comparable order intake and a 1% rise in comparable sales, reaching EUR 4.3 billion. The company achieved an income from operations of EUR 400 million, with an adjusted EBITA margin of 12.4%, up by 130 basis points. Free cash flow improved to EUR 230 million. Philips also updated its full-year outlook, increasing the adjusted EBITA margin range to 11.3%-11.8% and reiterating its comparable sales growth outlook of 1%-3%. The company highlighted strong order intake momentum, driven by AI-powered innovations, and a multi-year agreement with the Indonesian Ministry of Health to expand access to cardiac, stroke, and cancer care. CEO Roy Jakobs emphasized the company's focus on profitable growth, innovation, and patient safety.